Search research articles
Contact Us
Filters
Showing results (71-80 of 169) with videos related to
Page
of 17
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology
|
January 11, 2011
Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model
Caitlin W Hicks, Yan Li, Shu Okugawa, et al.
Journal of Hepatology
|
September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin
Zobair M Younossi, Maria Stepanova, Michael Estep, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 7, 2011
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3
Samir R Shah, Keyur Patel, Patrick Marcellin, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis
Michael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
ACS Biomaterials Science & Engineering
|
May 28, 2026
Dose-Dependent Effects of Dihydronicotinamide Riboside on Human Engineered Skeletal Muscle Development
Ashwin Venkateshvaran, Swarang Sachin Pundlik, Yavanica Suresh, et al.
Digestive Diseases and Sciences
|
September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B
Naoky C Tsai, Patrick Marcellin, Maria Buti, et al.
Hepatology International
|
May 6, 2016
Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India
Aracely Tamayo, Samir R Shah, Shobna Bhatia, et al.
Hepatology Communications
|
January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Anna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Antiviral Therapy
|
February 8, 2014
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor
David Nelson, Eric M Yoshida, Matthew S Paulson, et al.
Hepatology (Baltimore, Md.)
|
July 31, 2008
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C
Stefan Zeuzem, Eric M Yoshida, Yves Benhamou, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 169) with videos related to
Sort By:
Page
of 17
American Journal of Physiology. Heart and Circulatory Physiology
|
January 11, 2011
Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model
Caitlin W Hicks, Yan Li, Shu Okugawa, et al.
Journal of Hepatology
|
September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin
Zobair M Younossi, Maria Stepanova, Michael Estep, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 7, 2011
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3
Samir R Shah, Keyur Patel, Patrick Marcellin, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis
Michael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
ACS Biomaterials Science & Engineering
|
May 28, 2026
Dose-Dependent Effects of Dihydronicotinamide Riboside on Human Engineered Skeletal Muscle Development
Ashwin Venkateshvaran, Swarang Sachin Pundlik, Yavanica Suresh, et al.
Digestive Diseases and Sciences
|
September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B
Naoky C Tsai, Patrick Marcellin, Maria Buti, et al.
Hepatology International
|
May 6, 2016
Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India
Aracely Tamayo, Samir R Shah, Shobna Bhatia, et al.
Hepatology Communications
|
January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Anna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Antiviral Therapy
|
February 8, 2014
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor
David Nelson, Eric M Yoshida, Matthew S Paulson, et al.
Hepatology (Baltimore, Md.)
|
July 31, 2008
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C
Stefan Zeuzem, Eric M Yoshida, Yves Benhamou, et al.
Page
of 17